T. Cao

In Vivo Inhibition of Anti-Hepatitis B Virus Core Antigen (HBcAg) Immunoglobulin G Production by HBcAg-Specific CD4+ Th1-Type T-Cell Clones in a hu-PBL-NOD/SCID Mouse Model

G. Leroux-Roels, M. Sällberg, I. Desombere, 2001, Journal of Virology.

PREVENTION OF HEPATITIS B INFECTIONS : VACCINATION AND ITS LIMITATIONS

G. Leroux-Roels, P. Vanlandschoot, I. Desombere, 2001, Acta clinica Belgica.

Molecular Basis for the Interaction of the Hepatitis B Virus Core Antigen with the Surface Immunoglobulin Receptor on Naive B Cells

P. Pumpens, G. Leroux-Roels, M. Sällberg, 2001, Journal of Virology.

Hepatitis B Virus Core Antigen Binds and Activates Naive Human B Cells In Vivo: Studies with a Human PBL-NOD/SCID Mouse Model

G. Leroux-Roels, P. Vanlandschoot, M. Sällberg, 2001, Journal of Virology.

Antigen‐specific T cell responses in human peripheral blood leucocyte (hu‐PBL)–mouse chimera conditioned with radiation and an antibody directed against the mouse IL‐2 receptor β‐chain

G. Leroux-Roels, T. Cao, 2000, Clinical and experimental immunology.

Characterization of HLA DR13-restricted CD4(+) T cell epitopes of hepatitis B core antigen associated with self-limited, acute hepatitis B.

G. Leroux-Roels, P. Vanlandschoot, M. Sällberg, 2002, The Journal of general virology.

Non‐responsiveness to hepatitis B surface antigen vaccines is not caused by defective antigen presentation or a lack of B7 co‐stimulation

G. Leroux-Roels, I. Desombere, T. Cao, 2005, Clinical and experimental immunology.

Chimeric Antigen Receptor-Natural Killer Cells: A New Breakthrough in the Treatment of Solid Tumours.

Z. Chen, T. Cao, L. Yang, 2022, Clinical oncology (Royal College of Radiologists (Great Britain)).

The nucleocapsid of the hepatitis B virus: a remarkable immunogenic structure.

G. Leroux-Roels, P. Vanlandschoot, T. Cao, 2003, Antiviral research.